It is reported that strategies targeting at disrupting TGF−β1 synthesis and/or signaling pathways markedly reduce liver fibrosis (Li et al., 2021; Sun et al., 2021; Yang et al., 2021). Here, TGFB1 is linked to Hepatic fibrosis.